| Literature DB >> 34080086 |
Chaemin Lim1,2, Jin Kook Kang1, Chan Eun Jung1, Taehoon Sim1, Jaewon Her1, Kioh Kang1, Eun Seong Lee3, Yu Seok Youn4, Han-Gon Choi5, Kyung Taek Oh6.
Abstract
Lutein has been used as a dietary supplement for the treatment of eye diseases, especially age-related macular degeneration. For oral formulations, we investigated lutein stability in artificial set-ups mimicking different physiological conditions and found that lutein was degraded over time under acidic conditions. To enhance the stability of lutein upon oral intake, we developed enteric-coated lutein solid dispersions (SD) by applying a polymer, hydroxypropyl methylcellulose acetate succinate (HPMCAS-LF), through a solvent-controlled precipitation method. The SD were characterized in crystallinity, morphology, and drug entrapment. In the dissolution profile of lutein SD, a F80 formulation showed resistance toward the acidic environment under simulated gastric conditions while exhibiting a bursting drug release under simulated intestinal conditions. Our results highlight the potential use of HPMCAS-LF as an effective matrix to enhance lutein bioavailability during oral delivery and to provide novel insights into the eye-care supplement industry, with direct benefits for the health of patients.Entities:
Keywords: absorption; bioavailability; degradation; lutein; oral drug delivery; pH sensitivity; solid dispersion; stability
Mesh:
Substances:
Year: 2021 PMID: 34080086 DOI: 10.1208/s12249-021-02036-4
Source DB: PubMed Journal: AAPS PharmSciTech ISSN: 1530-9932 Impact factor: 3.246